Literature DB >> 18184651

EF domains are sufficient for nongenomic mineralocorticoid receptor actions.

Claudia Grossmann1, Ruth Freudinger, Sigrid Mildenberger, Britta Husse, Michael Gekle.   

Abstract

The mineralocorticoid receptor (MR) is important for salt homeostasis and reno-cardiovascular pathophysiology. Signaling mechanisms include, besides classical genomic pathways, nongenomic pathways with putative pathophysiological relevance involving the mitogen-activated protein kinases ERK1/2. We determined the MR domains required for nongenomic signaling and their potential to elicit pathophysiological effects in cultured cells under defined conditions. The expression of full-length human MR or truncated MR consisting of the domains CDEF (MR CDEF), DEF (MR DEF), or EF (MR EF) renders cells responsive for the MR ligand aldosterone with respect to nongenomic ERK1/2 phosphorylation, whereas only full-length MR and MR CDEF conferred genomic responsiveness. ERK1/2 phosphorylation depends on the EGF receptor and cSRC kinase. MR EF expression is sufficient to evoke the aldosterone-induced increase of collagen III levels, similar to full-length MR expression. Our data suggest that nongenomic MR signaling is mediated by the EF domains and present the first proof of principle showing that nongenomic signaling can be sufficient for some pathophysiological effects. The minimum amino acid motif required for nongenomic MR signaling and its importance in various effects have yet to be determined.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18184651     DOI: 10.1074/jbc.M708751200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Nongenomic glucocorticoid receptor action regulates gap junction intercellular communication and neural progenitor cell proliferation.

Authors:  Ranmal Aloka Samarasinghe; Roberto Di Maio; Daniela Volonte; Ferruccio Galbiati; Marcia Lewis; Guillermo Romero; Donald B DeFranco
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

2.  Mineralocorticoid accelerates transition to heart failure with preserved ejection fraction via "nongenomic effects".

Authors:  Selma F Mohammed; Tomohito Ohtani; Josef Korinek; Carolyn S P Lam; Katarina Larsen; Robert D Simari; Maria L Valencik; John C Burnett; Margaret M Redfield
Journal:  Circulation       Date:  2010-07-12       Impact factor: 29.690

3.  Elevated mineralocorticoid receptor activity in aged rat vascular smooth muscle cells promotes a proinflammatory phenotype via extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase and epidermal growth factor receptor-dependent pathways.

Authors:  Alexander W Krug; Lena Allenhöfer; Robert Monticone; Gaia Spinetti; Michael Gekle; Mingyi Wang; Edward G Lakatta
Journal:  Hypertension       Date:  2010-04-26       Impact factor: 10.190

Review 4.  Nuclear receptors outside the nucleus: extranuclear signalling by steroid receptors.

Authors:  Ellis R Levin; Stephen R Hammes
Journal:  Nat Rev Mol Cell Biol       Date:  2016-10-12       Impact factor: 94.444

Review 5.  Genomic and rapid effects of aldosterone: what we know and do not know thus far.

Authors:  Milla Marques Hermidorff; Leonardo Vinícius Monteiro de Assis; Mauro César Isoldi
Journal:  Heart Fail Rev       Date:  2017-01       Impact factor: 4.214

Review 6.  Rapid signaling by steroid receptors.

Authors:  Ellis R Levin
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-09-10       Impact factor: 3.619

7.  Caveolin-1 ablation reduces the adverse cardiovascular effects of N-omega-nitro-L-arginine methyl ester and angiotensin II.

Authors:  Luminita H Pojoga; Jose R Romero; Tham M Yao; Paul Loutraris; Vincent Ricchiuti; Patricia Coutinho; Christine Guo; Nathalie Lapointe; James R Stone; Gail K Adler; Gordon H Williams
Journal:  Endocrinology       Date:  2010-01-22       Impact factor: 4.736

8.  Actions of aldosterone in the cardiovascular system: the good, the bad, and the ugly?

Authors:  Michael Gekle; Claudia Grossmann
Journal:  Pflugers Arch       Date:  2008-11-19       Impact factor: 3.657

Review 9.  Nongenomic activation of phosphatidylinositol 3-kinase signaling by thyroid hormone receptors.

Authors:  Fumihiko Furuya; Changxue Lu; Celine J Guigon; Sheue-Yann Cheng
Journal:  Steroids       Date:  2008-10-30       Impact factor: 2.668

10.  Aldosterone receptor sites on plasma membrane of human vascular endothelium detected by a mechanical nanosensor.

Authors:  L Wildling; P Hinterdorfer; K Kusche-Vihrog; Y Treffner; H Oberleithner
Journal:  Pflugers Arch       Date:  2008-11-19       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.